PROM1 and cancer: In the current study, we demonstrated that combined treatment with cisplatin and curcumin reduced the expression of ABCG2 in CD133+ cancer stem cells, indicating that curcumin may suppress ABCG2-induced chemoresistance in CD133+ HEp-2 cells.